CIRRX | JABFX | CIRRX / JABFX | |
Total Expense Ratio | 1.25 | 1.92 | 65% |
Annual Report Gross Expense Ratio | 1.25 | 1.93 | 65% |
Fund Existence | 11 years | 5 years | - |
Gain YTD | 5.434 | -0.322 | -1,689% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.3B | 218M | 3,809% |
Annual Yield % from dividends | 2.37 | 0.95 | 248% |
Returns for 1 year | -2.06 | -3.54 | 58% |
Returns for 3 years | 24.03 | 9.21 | 261% |
Returns for 5 years | 29.91 | N/A | - |
Returns for 10 years | 59.74 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNAX | 72.17 | 1.04 | +1.46% |
Janus Henderson Global Life Sciences A | |||
JEVNX | 11.06 | 0.03 | +0.27% |
JHancock Disciplined Value Em Mkts EqNAV | |||
RICCX | 66.95 | 0.09 | +0.13% |
American Funds Invmt Co of Amer R3 | |||
KLCCX | 12.27 | N/A | N/A |
Federated Hermes Kaufmann Large Cap C | |||
FEQDX | 14.68 | N/A | N/A |
Fidelity Advisor Hedged Equity C |